BLT 17.1% 20.5¢ benitec biopharma limited

Sanofi Signs Benitec's closest competitor Voyager for $845M

  1. 2,300 Posts.
    lightbulb Created with Sketch. 8

    Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager
    February 11, 2015 | By John Carroll

    Sanofi subsidiary Genzyme is tying up with gene therapy upstart Voyager Therapeutics, gambling $100 million upfront on the hot field and promising up to $745 million in milestones for their partnership on a full slate of development programs.

    Here's Dirk's blog from a year ago when his buddy and ex boss Mark Kay's new Co Voyager was announced :
watchlist Created with Sketch. Add BLT (ASX) to my watchlist
(20min delay)
Mkt cap $44.98M
Open High Low Value Volume
17.5¢ 20.5¢ 17.5¢ $217.7K 1.136M

Buyers (Bids)

No. Vol. Price($)
1 15858 20.5¢

Sellers (Offers)

Price($) Vol. No.
21.0¢ 205119 4
Last update - 16.10pm 23/10/2018 (20 minute delay) ?
0.03 ( 20.6 %)
Open High   Low Volume
17.5¢ 20.5¢   17.5¢ 209795
Last updated 16.10pm 23/10/2018 (live) ?
BLT (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.